Genus plc (LON:GNS)
1,618.00
-24.00 (-1.46%)
Apr 17, 2025, 4:35 PM BST
Genus Revenue
Genus had revenue of 336.40M GBP in the half year ending December 31, 2024, a decrease of -3.94%. This brings the company's revenue in the last twelve months to 671.60M, down -0.22% year-over-year. In the fiscal year ending June 30, 2024, Genus had annual revenue of 668.80M, down -3.03%.
Revenue (ttm)
671.60M
Revenue Growth
-0.22%
P/S Ratio
1.58
Revenue / Employee
191.89K
Employees
3,500
Market Cap
1.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
Jun 30, 2020 | 551.40M | 62.90M | 12.88% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Genus News
- 6 weeks ago - Genus plc goes ex dividend Monday - Seeking Alpha
- 7 weeks ago - Genus plc (GENSF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Half Year 2025 Genus PLC Earnings Call Transcript - GuruFocus
- 4 months ago - Genius Group increases Bitcoin treasury to 214 Bitcoin - Seeking Alpha
- 4 months ago - Genius Group acquires XD Academy, bitcoin learning platform - Seeking Alpha
- 5 months ago - Genius Group stock tumbles after H1 prelim results - Seeking Alpha
- 7 months ago - GNS cuts in NZ could ‘devastate’ critical work according to 85 international scientists that study risks from tsunami, earthquakes, disasters - NZ Herald
- 7 months ago - Why Is Nano Nuclear Stock Jumping Today? - Benzinga